EVP R&D, Chief Medical Officer of Alkermes Plc (30-Year Financial, Insider Trades) Craig C. Hopkinson (insider trades) sold 28,920 shares of ALKS on 04/15/2021 at an average price of $19.72 a share. The total sale was $570,302.
Alkermes PLC is a fully integrated, biopharmaceutical company. It applies its scientific expertise and proprietary technologies to research, develop and commercialize pharmaceutical products to address unmet medical needs of patients. Alkermes Plc has a market cap of $3.16 billion; its shares were traded at around $19.870000 with and P/S ratio of 3.04. Alkermes Plc had an annual average EBITDA growth of 38.60% over the past 5 years.
Directors and Officers Recent Trades:
- EVP R&D, Chief Medical Officer Craig C. Hopkinson sold 28,920 shares of ALKS stock on 04/15/2021 at the average price of $19.72. The price of the stock has increased by 0.76% since.
For the complete insider trading history of ALKS, click here.